Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response

DNA Repair

Volumn 8, Issue 9, 2009, Pages 1047-1054

  Stracker, Travis H ^a,c   Usui, Takehiko ^a   Petrini, John H J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

Author keywords

Apoptosis; ATM; ATR; Cell cycle; Checkpoint; Chk1; Chk2; DNA repair; Mre11; Nbs1; Rad50; Rad53; Rad9; Recombination; Tel1; Transcription

Indexed keywords

CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; DNA;

ARTICLE; DNA DAMAGE; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE; GENETIC CONSERVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; SIGNAL TRANSDUCTION;

DISEASE; DNA DAMAGE; ENZYME ACTIVATION; HUMANS; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES;

MAMMALIA; SACCHAROMYCETALES; SCHIZOSACCHAROMYCES POMBE; SCHIZOSACCHAROMYCETACEAE;

EID: 68249126215     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2009.04.012     Document Type: Article

References (135)

1. Ahn J., Urist M., and Prives C. The Chk2 protein kinase. DNA Repair (Amst.) 3 (2004) 1039-1047
2. Kass E.M., Ahn J., Tanaka T., Freed-Pastor W.A., Keezer S., and Prives C. Stability of checkpoint kinase 2 is regulated via phosphorylation at serine 456. J. Biol. Chem. 282 (2007) 30311-30321
3. Gabant G., Lorphelin A., Nozerand N., Marchetti C., Bellanger L., Dedieu A., Quemeneur E., and Alpha-Bazin B. Autophosphorylated residues involved in the regulation of human chk2 in vitro. J. Mol. Biol. 380 (2008) 489-503
4. Lovly C.M., Yan L., Ryan C.E., Takada S., and Piwnica-Worms H. Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379. Mol. Cell. Biol. (2008)
5. Scorah J., Dong M.Q., Yates J.R., 3rd M., Scott D., Gillespie C.H., and McGowan. A conserved proliferating cell nuclear antigen-interacting protein sequence in Chk1 is required for checkpoint function. J. Biol. Chem. 283 (2008) 17250-17259
6. Katsuragi Y., and Sagata N. Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation. Mol. Biol. Cell. 15 (2004) 1680-1689
7. Kosoy A., and O'Connell M.J. Regulation of Chk1 by its C-terminal domain. Mol. Biol. Cell. (2008)
8. Lee J.H., and Paull T.T. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26 (2007) 7741-7748
9. Parrilla-Castellar E.R., Arlander S.J., and Karnitz L. Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair (Amst) 3 (2004) 1009-1014
10. Cimprich K.A., and Cortez D. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell. Biol. 9 (2008) 616-627
11. Mordes D.A., and Cortez D. Activation of ATR and related PIKKs. Cell Cycle. (2008) 7
12. Oliver A.W., Knapp S., and Pearl L.H. Activation segment exchange: a common mechanism of kinase autophosphorylation?. Trends Biochem. Sci. 32 (2007) 351-356
13. Xu Y.J., Davenport M., and Kelly T.J. Two-stage mechanism for activation of the DNA replication checkpoint kinase Cds1 in fission yeast. Genes Dev. 20 (2006) 990-1003
14. Gatei M., Sloper K., Sorensen C., Syljuasen R., Falck J., Hobson K., Savage K., Lukas J., Zhou B.B., Bartek J., and Khanna K.K. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem. 278 (2003) 14806-14811
15. Garcia-Muse T., and Boulton S.J. Distinct modes of ATR activation after replication stress and DNA double-strand breaks in Caenorhabditis elegans. EMBO J. 24 (2005) 4345-4355
16. Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C., Lukas J., and Jackson S.P. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell. Biol. 8 (2006) 37-45
17. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., and Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10389-10394
18. Hirao A., Cheung A., Duncan G., Girard P.M., Elia A.J., Wakeham A., Okada H., Sarkissian T., Wong J.A., Sakai T., De Stanchina E., Bristow R.G., Suda T., Lowe S.W., Jeggo P.A., Elledge S.J., and Mak T.W. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol. Cell. Biol. 22 (2002) 6521-6532
19. Goudelock D.M., Jiang K., Pereira E., Russell B., and Sanchez Y. Regulatory interactions between the checkpoint kinase Chk1 and the proteins of the DNA-dependent protein kinase complex. J. Biol. Chem. 278 (2003) 29940-29947
20. McSherry T.D., and Mueller P.R. Xenopus Cds1 is regulated by DNA-dependent protein kinase and ATR during the cell cycle checkpoint response to double-stranded DNA ends. Mol. Cell. Biol. 24 (2004) 9968-9985
21. Li J., and Stern D.F. Regulation of CHK2 by DNA-dependent protein kinase. J. Biol. Chem. 280 (2005) 12041-12050
22. Stracker T.H., Couto S.S., Cordon-Cardo C., Matos T., and Petrini J.H. Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage. Mol. Cell. 31 (2008) 21-32
23. Pellicioli A., and Foiani M. Signal transduction: how rad53 kinase is activated. Curr. Biol. 15 (2005) R769-R771
24. Chen S.H., Smolka M.B., and Zhou H. Mechanism of Dun1 activation by Rad53 phosphorylation in Saccharomyces cerevisiae. J. Biol. Chem. 282 (2007) 986-995
25. Usui T., and Petrini J.H. The Saccharomyces cerevisiae 14-3-3 proteins Bmh1 and Bmh2 directly influence the DNA damage-dependent functions of Rad53. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 2797-2802
26. Fiorani S., Mimun G., Caleca L., Piccini D., and Pellicioli A. Characterization of the activation domain of the Rad53 checkpoint kinase. Cell Cycle 7 (2008) 493-499
27. Usui T., Foster S., and Petrini J.H. Maintenance of the DNA damage checkpoint requires mediator protein oligomerization. Mol Cell. 33 (2009) 147-159
28. Wang B., Matsuoka S., Carpenter P.B., and Elledge S.J. 53BP1, a mediator of the DNA damage checkpoint. Science 298 (2002) 1435-1438
29. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., and Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421 (2003) 961-966
30. Mochan T.A., Venere M., DiTullio Jr. R.A., and Halazonetis T.D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 63 (2003) 8586-8591
31. Lou Z., Minter-Dykhouse K., Wu X., and Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421 (2003) 957-961
32. Lou Z., Minter-Dykhouse K., Franco S., Gostissa M., Rivera M.A., Celeste A., Manis J.P., van Deursen J., Nussenzweig A., Paull T.T., Alt F.W., and Chen J. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell. 21 (2006) 187-200
33. Minter-Dykhouse K., Ward I., Huen M.S., Chen J., and Lou Z. Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis. J. Cell. Biol. 181 (2008) 727-735
34. Kumagai A., Dunphy W.G., and Claspin. a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol. Cell. 6 (2000) 839-849
35. Wang X., Zou L., Lu T., Bao S., Hurov K.E., Hittelman W.N., Elledge S.J., and Li L. Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stress. Mol. Cell. 23 (2006) 331-341
36. Kumagai A., and Dunphy W.G. Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. Nat. Cell. Biol. 5 (2003) 161-165
37. Chini C.C., and Chen J. Repeated phosphopeptide motifs in human Claspin are phosphorylated by Chk1 and mediate Claspin function. J. Biol. Chem. 281 (2006) 33276-33282
38. Chini C.C., Wood J., and Chen J. Chk1 is required to maintain claspin stability. Oncogene 25 (2006) 4165-4171
39. Smits V.A., Reaper P.M., and Jackson S.P. Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr. Biol. 16 (2006) 150-159
40. Kramer A., Mailand N., Lukas C., Syljuasen R.G., Wilkinson C.J., Nigg E.A., Bartek J., and Lukas J. Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat. Cell. Biol. 6 (2004) 884-891
41. Niida H., Katsuno Y., Banerjee B., Hande M.P., and Nakanishi M. Specific role of Chk1 phosphorylations in cell survival and checkpoint activation. Mol. Cell. Biol. 27 (2007) 2572-2581
42. Zhang Y.W., Otterness D.M., Chiang G.G., Xie W., Liu Y.C., Mercurio F., and Abraham R.T. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell. 19 (2005) 607-618
43. Puc J., Keniry M., Li H.S., Pandita T.K., Choudhury A.D., Memeo L., Mansukhani M., Murty V.V., Gaciong Z., Meek S.E., Piwnica-Worms H., Hibshoosh H., and Parsons R. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell. 7 (2005) 193-204
44. Henderson M.J., Munoz M.A., Saunders D.N., Clancy J.L., Russell A.J., Williams B., Pappin D., Khanna K.K., Jackson S.P., Sutherland R.L., and Watts C.K. EDD mediates DNA damage-induced activation of CHK2. J. Biol. Chem. 281 (2006) 39990-40000
45. Chen L., Gilkes D.M., Pan Y., Lane W.S., and Chen J. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J. 24 (2005) 3411-3422
46. LeBron C., Chen L., Gilkes D.M., and Chen J. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. EMBO J. 25 (2006) 1196-1206
47. Jin Y., Dai M.S., Lu S.Z., Xu Y., Luo Z., Zhao Y., and Lu H. 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J. 25 (2006) 1207-1218
48. Zhang D., Zaugg K., Mak T.W., and Elledge S.J. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 126 (2006) 529-542
49. Bartek J., and Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 3 (2003) 421-429
50. Karlsson-Rosenthal C., and Millar J.B. Cdc25: mechanisms of checkpoint inhibition and recovery. Trends Cell. Biol. 16 (2006) 285-292
51. Boutros R., Dozier C., and Ducommun B. The when and wheres of CDC25 phosphatases. Curr. Opin. Cell. Biol. 18 (2006) 185-191
52. Busino L., Donzelli M., Chiesa M., Guardavaccaro D., Ganoth D., Dorrello N.V., Hershko A., Pagano M., and Draetta G.F. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426 (2003) 87-91
53. Jin J., Shirogane T., Xu L., Nalepa G., Qin J., Elledge S.J., and Harper J.W. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17 (2003) 3062-3074
54. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., and Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277 (1997) 1501-1505
55. Kanemori Y., Uto K., and Sagata N. Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 6279-6284
56. Peschiaroli A., Dorrello N.V., Guardavaccaro D., Venere M., Halazonetis T., Sherman N.E., and Pagano M. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol. Cell. 23 (2006) 319-329
57. Mailand N., Bekker-Jensen S., Bartek J., and Lukas J. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol. Cell 23 (2006) 307-318
58. Bassermann F., Frescas D., Guardavaccaro D., Busino L., Peschiaroli A., and Pagano M. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 134 (2008) 256-267
59. Sorensen C.S., Hansen L.T., Dziegielewski J., Syljuasen R.G., Lundin C., Bartek J., and Helleday T. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell. Biol. 7 (2005) 195-201
60. Wang X., Kennedy R.D., Ray K., Stuckert P., Ellenberger T., and D'Andrea A.D. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 27 (2007) 3098-3108
61. Collis S.J., Barber L.J., Clark A.J., Martin J.S., Ward J.D., and Boulton S.J. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat. Cell. Biol. 9 (2007) 391-401
62. Takai H., Wang R.C., Takai K.K., Yang H., and de Lange T. Tel2 regulates the stability of PI3K-related protein kinases. Cell 131 (2007) 1248-1259
63. Bahassi E.M., Ovesen J.L., Riesenberg A.L., Bernstein W.Z., Hasty P.E., and Stambrook P.J. The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage. Oncogene 27 (2008) 3977-3985
64. Pasero P., Shimada K., and Duncker B.P. Multiple roles of replication forks in S phase checkpoints: sensors, effectors and targets. Cell Cycle 2 (2003) 568-572
65. Branzei D., and Foiani M. The Rad53 signal transduction pathway: replication fork stabilization, DNA repair, and adaptation. Exp. Cell. Res. 312 (2006) 2654-2659
66. Segurado M., and Diffley J.F. Separate roles for the DNA damage checkpoint protein kinases in stabilizing DNA replication forks. Genes Dev. 22 (2008) 1816-1827
67. Morin I., Ngo H.P., Greenall A., Zubko M.K., Morrice N., and Lydall D. Checkpoint-dependent phosphorylation of Exo1 modulates the DNA damage response. EMBO J. 27 (2008) 2400-2410
68. Yang X.H., Shiotani B., Classon M., and Zou L. Chk1 and Claspin potentiate PCNA ubiquitination. Genes Dev. 22 (2008) 1147-1152
69. Errico A., Costanzo V., and Hunt T. Tipin is required for stalled replication forks to resume DNA replication after removal of aphidicolin in Xenopus egg extracts. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 14929-14934
70. Yoshizawa-Sugata N., and Masai H. Human Tim/Timeless-interacting protein, Tipin, is required for efficient progression of S phase and DNA replication checkpoint. J. Biol. Chem. 282 (2007) 2729-2740
71. Durkin S.G., Arlt M.F., Howlett N.G., and Glover T.W. Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene 25 (2006) 4381-4388
72. Wittenberg C., and Reed S.I. Cell cycle-dependent transcription in yeast: promoters, transcription factors, and transcriptomes. Oncogene 24 (2005) 2746-2755
73. de Bruin R.A., Kalashnikova T.I., Aslanian A., Wohlschlegel J., Chahwan C., Yates III J.R., Russell P., and Wittenberg C. DNA replication checkpoint promotes G1-S transcription by inactivating the MBF repressor Nrm1. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 11230-11235
74. Dutta C., Patel P.K., Rosebrock A., Oliva A., Leatherwood J., and Rhind N. The DNA replication checkpoint directly regulates MBF-dependent G1/S transcription. Mol. Cell. Biol. (2008)
75. Lee H., Yuan C., Hammet A., Mahajan A., Chen E.S., Wu M.R., Su M.I., Heierhorst J., and Tsai M.D. Diphosphothreonine-specific interaction between an SQ/TQ cluster and an FHA domain in the Rad53-Dun1 kinase cascade. Mol. Cell. 30 (2008) 767-778
76. Huang M., Zhou Z., and Elledge S.J. The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor. Cell 94 (1998) 595-605
77. Stevens C., Smith L., and La Thangue N.B. Chk2 activates E2F-1 in response to DNA damage. Nat. Cell. Biol. 5 (2003) 401-409
78. Urist M., Tanaka T., Poyurovsky M.V., and Prives C. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18 (2004) 3041-3054
79. Inoue Y., Kitagawa M., and Taya Y. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J. 26 (2007) 2083-2093
80. Stevens C., and La Thangue N.B. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 3 (2004) 1071-1079
81. Rogoff H.A., Pickering M.T., Frame F.M., Debatis M.E., Sanchez Y., Jones S., and Kowalik T.F. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol. Cell. Biol. 24 (2004) 2968-2977
82. Takai H., Naka K., Okada Y., Watanabe M., Harada N., Saito S., Anderson C.W., Appella E., Nakanishi M., Suzuki H., Nagashima K., Sawa H., Ikeda K., and Motoyama N. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 21 (2002) 5195-5205
83. MacPherson D., Kim J., Kim T., Rhee B.K., Van Oostrom C.T., DiTullio R.A., Venere M., Halazonetis T.D., Bronson R., De Vries A., Fleming M., and Jacks T. Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J. 23 (2004) 3689-3699
84. Pereg Y., Lam S., Teunisse A., Biton S., Meulmeester E., Mittelman L., Buscemi G., Okamoto K., Taya Y., Shiloh Y., and Jochemsen A.G. Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage. Mol. Cell. Biol. 26 (2006) 6819-6831
85. Bruno T., De Nicola F., Iezzi S., Lecis D., D'Angelo C., Di Padova M., Corbi N., Dimiziani L., Zannini L., Jekimovs C., Scarsella M., Porrello A., Chersi A., Crescenzi M., Leonetti C., Khanna K.K., Soddu S., Floridi A., Passananti C., Delia D., and Fanciulli M. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell. 10 (2006) 473-486
86. Wang Z.G., Ruggero D., Ronchetti S., Zhong S., Gaboli M., Rivi R., and Pandolfi P.P. PML is essential for multiple apoptotic pathways. Nat. Genet. 20 (1998) 266-272
87. Yang S., Kuo C., Bisi J.E., and Kim M.K. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat. Cell. Biol. 4 (2002) 865-870
88. Dellaire G., Ching R.W., Ahmed K., Jalali F., Tse K.C., Bristow R.G., and Bazett-Jones D.P. Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J. Cell. Biol. 175 (2006) 55-66
89. Sidi S., Sanda T., Kennedy R.D., Hagen A.T., Jette C.A., Hoffmans R., Pascual J., Imamura S., Kishi S., Amatruda J.F., Kanki J.P., Green D.R., D'Andrea A.A., and Look A.T. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 133 (2008) 864-877
90. Huang H., Regan K.M., Lou Z., Chen J., and Tindall D.J. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314 (2006) 294-297
91. Yuan Z., Becker E.B., Merlo P., Yamada T., DiBacco S., Konishi Y., Schaefer E.M., and Bonni A. Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons. Science 319 (2008) 1665-1668
92. Shimada M., Niida H., Zineldeen D.H., Tagami H., Tanaka M., Saito H., and Nakanishi M. Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell 132 (2008) 221-232
93. Hu F., Alcasabas A.A., and Elledge S.J. Asf1 links Rad53 to control of chromatin assembly. Genes Dev. 15 (2001) 1061-1066
94. Schwartz M.F., Lee S.J., Duong J.K., Eminaga S., and Stern D.F. FHA domain-mediated DNA checkpoint regulation of Rad53. Cell Cycle 2 (2003) 384-396
95. Lee S.J., Schwartz M.F., Duong J.K., and Stern D.F. Rad53 phosphorylation site clusters are important for Rad53 regulation and signaling. Mol. Cell. Biol. 23 (2003) 6300-6314
96. Sillje H.H., Takahashi K., Tanaka K., Van Houwe G., and Nigg E.A. Mammalian homologues of the plant Tousled gene code for cell-cycle-regulated kinases with maximal activities linked to ongoing DNA replication. EMBO J. 18 (1999) 5691-5702
97. Groth A., Lukas J., Nigg E.A., Sillje H.H., Wernstedt C., Bartek J., and Hansen K. Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint. EMBO J. 22 (2003) 1676-1687
98. Krause D.R., Jonnalagadda J.C., Gatei M.H., Sillje H.H., Zhou B.B., Nigg E.A., and Khanna K. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene 22 (2003) 5927-5937
99. Sillje H.H., and Nigg E.A. Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases. Curr. Biol. 11 (2001) 1068-1073
100. Chen C.C., Carson J.J., Feser J., Tamburini B., Zabaronick S., Linger J., and Tyler J.K. Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair. Cell 134 (2008) 231-243
101. Pellicioli A., Lee S.E., Lucca C., Foiani M., and Haber J.E. Regulation of Saccharomyces Rad53 checkpoint kinase during adaptation from DNA damage-induced G2/M arrest. Mol. Cell. 7 (2001) 293-300
102. Leroy C., Lee S.E., Vaze M.B., Ochsenbien F., Guerois R., Haber J.E., and Marsolier-Kergoat M.C. PP2C phosphatases Ptc2 and Ptc3 are required for DNA checkpoint inactivation after a double-strand break. Mol. Cell. 11 (2003) 827-835
103. Marsolier M.C., Roussel P., Leroy C., and Mann C. Involvement of the PP2C-like phosphatase Ptc2p in the DNA checkpoint pathways of Saccharomyces cerevisiae. Genetics 154 (2000) 1523-1532
104. O'Neill B.M., Szyjka S.J., Lis E.T., Bailey A.O., Yates J.R., 3rd O.M., Aparicio F.E., and Romesberg. Pph3-Psy2 is a phosphatase complex required for Rad53 dephosphorylation and replication fork restart during recovery from DNA damage. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 9290-9295
105. Szyjka S.J., Aparicio J.G., Viggiani C.J., Knott S., Xu W., Tavare S., and Aparicio O.M. Rad53 regulates replication fork restart after DNA damage in Saccharomyces cerevisiae. Genes Dev. 22 (2008) 1906-1920
106. den Elzen N.R., and O'Connell M.J. Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1. EMBO J. 23 (2004) 908-918
107. Fiscella M., Zhang H., Fan S., Sakaguchi K., Shen S., Mercer W.E., Vande Woude G.F., O'Connor P.M., Appella E., and Wip1. a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6048-6053
108. Lu X., Nannenga B., and Donehower L.A. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 19 (2005) 1162-1174
109. Fujimoto H., Onishi N., Kato N., Takekawa M., Xu X.Z., Kosugi A., Kondo T., Imamura M., Oishi I., Yoda A., and Minami Y. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ. 13 (2006) 1170-1180
110. Shreeram S., Demidov O.N., Hee W.K., Yamaguchi H., Onishi N., Kek C., Timofeev O.N., Dudgeon C., Fornace A.J., Anderson C.W., Minami Y., Appella E., and Bulavin D.V. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol. Cell. 23 (2006) 757-764
111. Nannenga B., Lu X., Dumble M., Van Maanen M., Nguyen T.A., Sutton R., Kumar T.R., and Donehower L.A. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice. Mol. Carcinog. 45 (2006) 594-604
112. Oliva-Trastoy M., Berthonaud V., Chevalier A., Ducrot C., Marsolier-Kergoat M.C., Mann C., and Leteurtre F. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase. Oncogene 26 (2007) 1449-1458
113. Dozier C., Bonyadi M., Baricault L., Tonasso L., and Darbon J.M. Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit. Biol. Cell. 96 (2004) 509-517
114. Goodarzi A.A., Jonnalagadda J.C., Douglas P., Young D., Ye R., Moorhead G.B., Lees-Miller S.P., and Khanna K.K. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J. 23 (2004) 4451-4461
115. Petersen P., Chou D.M., You Z., Hunter T., Walter J.C., and Walter G. Protein phosphatase 2A antagonizes ATM and ATR in a Cdk2- and Cdc7-independent DNA damage checkpoint. Mol. Cell. Biol. 26 (2006) 1997-2011
116. Margolis S.S., Perry J.A., Forester C.M., Nutt L.K., Guo Y., Jardim M.J., Thomenius M.J., Freel C.D., Darbandi R., Ahn J.H., Arroyo J.D., Wang X.F., Shenolikar S., Nairn A.C., Dunphy W.G., Hahn W.C., Virshup D.M., and Kornbluth S. Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 127 (2006) 759-773
117. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., and Halazonetis T.D. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
118. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., and Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
119. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., Appella E., and Fornace Jr. A.J. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36 (2004) 343-350
120. Nevanlinna H., and Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25 (2006) 5912-5919
121. Bahassi el M., Penner C.G., Robbins S.B., Tichy E., Feliciano E., Yin M., Liang L., Deng L., Tischfield J.A., and Stambrook P.J. The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model. Mutat. Res. 616 (2007) 201-209
122. Kwak E.L., Kim S., Zhang J., Cardiff R.D., Schmidt E.V., and Haber D.A. Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant. Cancer Res. 66 (2006) 1923-1928
123. McPherson J.P., Lemmers B., Hirao A., Hakem A., Abraham J., Migon E., Matysiak-Zablocki E., Tamblyn L., Sanchez-Sweatman O., Khokha R., Squire J., Hande M.P., Mak T.W., and Hakem R. Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev. 18 (2004) 1144-1153
124. Cao L., Kim S., Xiao C., Wang R.H., Coumoul X., Wang X., Li W.M., Xu X.L., De Soto J.A., Takai H., Mai S., Elledge S.J., Motoyama N., and Deng C.X. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J. 25 (2006) 2167-2177
125. Kim S.S., Cao L., Li C., Xu X., Huber L.J., Chodosh L.A., and Deng C.X. Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1. Mol. Cell. Biol. 24 (2004) 9498-9507
126. Lam M.H., Liu Q., Elledge S.J., and Rosen J.M. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell. 6 (2004) 45-59
127. Liu Q., Guntuku S., Cui X.S., Matsuoka S., Cortez D., Tamai K., Luo G., Carattini-Rivera S., DeMayo F., Bradley A., Donehower L.A., and Elledge S.J. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14 (2000) 1448-1459
128. Takai H., Tominaga K., Motoyama N., Minamishima Y.A., Nagahama H., Tsukiyama T., Ikeda K., Nakayama K., and Nakanishi M. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev. 14 (2000) 1439-1447
129. O'Driscoll M., Ruiz-Perez V.L., Woods C.G., Jeggo P.A., and Goodship J.A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33 (2003) 497-501
130. Xu X., Lee J., and Stern D.F. Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1. J. Biol. Chem. 279 (2004) 34091-34094
131. Lin S.Y., Rai R., Li K., Xu Z.X., and Elledge S.J. BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15105-15109
132. Alderton G.K., Galbiati L., Griffith E., Surinya K.H., Neitzel H., Jackson A.P., Jeggo P.A., and O'Driscoll M. Regulation of mitotic entry by microcephalin and its overlap with ATR signalling. Nat. Cell. Biol. 8 (2006) 725-733
133. Zhou B.B., and Bartek J. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat. Rev. Cancer 4 (2004) 216-225
134. Antoni L., Sodha N., Collins I., and Garrett M.D. CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?. Nat. Rev. Cancer 7 (2007) 925-936
135. O'Connor M.J., Martin N.M., and Smith G.C. Targeted cancer therapies based on the inhibition of DNA strand break repair. Oncogene 26 (2007) 7816-7824